Vivoryon Therapeutics N.V.
$1.05▲ 5.00%(+$0.05)
TickerSpark Score
51/100
▌ Mixed
60
Valuation
20
Profitability
60
Growth
84
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VVY.AS research report →
52-Week Range6% of range
Low
$1.00
Current
$1.05
High
$1.84
Company Overviewwww.vivoryon.com
About the company
Vivoryon Therapeutics N. V. is a clinical-stage biopharmaceutical firm dedicated to discovering and developing novel treatments for Alzheimer's disease.
- CEO
- Frank T. Weber
- IPO
- 2014
- Employees
- 14
- HQ
- Halle, DE
Price Chart
-28.08% · this period
Valuation
- Market Cap
- $31.10M
- P/E
- -3.18
- P/S
- 0.00
- P/B
- 6.36
- EV/EBITDA
- -2.82
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -223.90%
- ROIC
- -136.06%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-8,853,000 · 56.96%
- EPS
- $-0.33 · 58.23%
- Op Income
- $-9,177,000
- FCF YoY
- 55.88%
Performance & Tape
- 52W High
- $1.84
- 52W Low
- $1.00
- 50D MA
- $1.24
- 200D MA
- $1.44
- Beta
- 1.39
- Avg Volume
- 50.86K
Get TickerSpark's AI analysis on VVY.AS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Coverage · VVY.AS
Our VVY.AS coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on VVY.AS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VVY.AS report →Internal Compare
Similar companies
Peers in the same neighborhood.